Honiball John Robert, Pepper Michael Sean, Prinsloo Earl
Biotechnology Innovation Centre, Faculty of Science, Rhodes University, Grahamstown, South Africa.
Department of Immunology, Institute for Cellular and Molecular Medicine, University of Pretoria, Pretoria, South Africa.
MethodsX. 2020 Dec 17;8:101186. doi: 10.1016/j.mex.2020.101186. eCollection 2021.
Bioprinting is a rapidly expanding technology with the ability to fabricate in vitro three-dimensional (3D) tissues in a layer-by-layer manner to ultimately produce a living tissue which physiologically resembles native in vivo tissue functionality. Unfortunately, large costs associated with commercially available bioprinters severely limit access to the technology. We investigated the potential for modifying a low-cost commercially available RepRap Prusa iteration 3 (i3) 3D printer with an open-source syringe-housed microextrusion print-head unit (universal paste extruder by Richard Horne, RichRap), that allowed for controlled deposition of cell-laden bioinks and Freeform Reversible Embedding of Suspended Hydrogels (FRESH) method-based printing.
生物打印是一项迅速发展的技术,它能够以逐层方式制造体外三维(3D)组织,最终生产出在生理功能上类似于天然体内组织的活组织。不幸的是,与市售生物打印机相关的高昂成本严重限制了该技术的应用。我们研究了用开源注射器式微挤压打印头单元(Richard Horne的通用糊剂挤出机,RichRap)改装低成本市售RepRap Prusa迭代3(i3)3D打印机的潜力,该打印头单元允许对载有细胞的生物墨水进行可控沉积,并基于悬浮水凝胶的自由形式可逆嵌入(FRESH)方法进行打印。